Drugs / Relacatib
Relacatib
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00411190 | Oct → Dec 2006 | osteoarthritis | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Relacatib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00411190 ↗ |
| Known as | CPD 10 | ChEMBL registry synonym — accepted as the source's own label CHEMBL203665 ↗ |
| Known as | GSK-462795 | ChEMBL registry synonym — accepted as the source's own label CHEMBL203665 ↗ |
| Known as | SB-462795 | ChEMBL registry synonym — accepted as the source's own label CHEMBL203665 ↗ |
| Modality | Small molecule | — CHEMBL203665 ↗ |